Regulatory Dashboard | GMO Regulatory Considerations for Advanced Therapies in Europe

In the European Union (EU), gene therapy medicinal products (GTMP) are a subset of advanced therapy medicinal products (ATMPs) and may consist of or contain genetically modified organisms (GMOs). The EU GMO frameworks were developed to address environmental concerns related to GMOs for agricultural use.

"*" indicates required fields

Please enter your details to get access to the resource

By submitting this form, you consent to your personal data submitted in the form being processed in alignment with our Online Privacy and Cookies policy. Your personal data will be processed to facilitate your request and may be used for sending you additional marketing and business development-related information about Ergomed, its affiliates, and our services. You can withdraw your consent anytime by messaging marketing@wordpress-546467-1930493.cloudwaysapps.com, and we will promptly remove your data from our records. For more information about how we will process your personal data and your rights, please see our Online Privacy and Cookies policy.
This field is for validation purposes and should be left unchanged.